Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases ; volume:6 ; number:1 ; day:31 ; month:8 ; year:2018 ; pages:1-6 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (31.8.2018), 1-6, 12.2018
- Urheber
-
Garcia, Christine A.
- Beteiligte Personen und Organisationen
-
El-Ali, Alex
Rath, Tanya J.
Contis, Lydia C.
Gorantla, Vikram
Drappatz, Jan
Davar, Diwakar
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0393-z
- URN
-
urn:nbn:de:101:1-2018102113025472113342
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Garcia, Christine A.
- El-Ali, Alex
- Rath, Tanya J.
- Contis, Lydia C.
- Gorantla, Vikram
- Drappatz, Jan
- Davar, Diwakar
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neurologic adverse events of cancer immunotherapy
Managing immune-related adverse events in oncology
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
Corticosteroid-resistant immune-related adverse events: a systematic review
Nivolumab adjuvant, Nivolumab plus Ipilimumab : Meilensteine in der Behandlung des malignen Melanoms
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
The role of tumor types in immune-related adverse events
Neurologic adverse events of cancer immunotherapy
Managing immune-related adverse events in oncology
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
Corticosteroid-resistant immune-related adverse events: a systematic review
Nivolumab adjuvant, Nivolumab plus Ipilimumab : Meilensteine in der Behandlung des malignen Melanoms
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
The role of tumor types in immune-related adverse events
Neurologic adverse events of cancer immunotherapy
Managing immune-related adverse events in oncology
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report
Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
Corticosteroid-resistant immune-related adverse events: a systematic review
Nivolumab adjuvant, Nivolumab plus Ipilimumab : Meilensteine in der Behandlung des malignen Melanoms
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer